Results for potent cyp3a4 inhibitors translation from English to Estonian

potent cyp3a4 inhibitors
tugevad cyp3a4 inhibiitorid

potent cyp3a4/pgp inhibitors
tugevad cyp3a4/pgp inhibiitorid

cyp3a4 inhibitors
cyp3a4 inhibeerijad

potent cyp3a4 inducers
tugeva toimega cyp3a4 indutseerijad

moderate(3) or potent(4) cyp3a4 inhibitors
mõõduka(3) või tugeva(4) toimega cyp3a4 inhibiitorid

see section 4.5 (4) potent cyp3a4 inhibitors.
(4) tugevad cyp3a4 inhibiitorid.

indinavir is a potent cyp3a4 inhibitor.
indinaviir on tugev cyp3a4 inhibiitor kontsentratsiooni.

a similar increase in exposure is expected with other potent cyp3a4 inhibitors.
samasugust süsteemse saadavuse tõusu võib eeldada teistegi cyp3a4 tugevatoimeliste inhibiitorite mõjul.

grapefruit juice is also a potent cyp3a4 inhibitor.
ka greibimahl on tugev cyp3a4 inhibiitor.

patients should be closely monitored when given bortezomib in combination with potent cyp3a4 inhibitors.
hoolikalt on vaja jälgida patsiente, kellele samaaegselt bortesomiibiga manustatakse tugevatoimelisi cyp3a4 inhibiitoreid.

cyp3a4 inhibitor]
inhibiitor]

not studied, but both are potent cyp3a4 inhibitors and would be expected to increase maraviroc concentrations.
ei ole uuritud, kuid mõlemad on tugevad cyp3a4 inhibiitorid ja suurendavad tõenäoliselt maraviroki kontsentratsiooni.

concomitant administration of potent cyp3a4 inhibitors is contraindicated (see sections 4.3 and 4.5).
tugevate cyp3a4 inhibiitorite samaaegne manustamine on vastunäidustatud (vt lõigud 4.3 ja 4.5).

without potent cyp3a4 inhibitors or co- administered with tipranavir/ ritonavir if coadministered with potent cyp3a4
inhibiitorita või koosmanustamisel tipranaviiri/ ritonaviiriga

oral ritonavir, one of the most potent cyp3a4 inhibitors, reduced the clearance of intravenous fentanyl by two thirds.
suukaudne ritonaviir kui üks tugevamaid cyp3a4 inhibiitoreid vähendas intravenoosse fentanüüli kliirensit kahe kolmandiku võrra.

ritonavir (potent cyp450 inducer; cyp3a4 inhibitor and substrate)
ritonaviir (tugev cyp450 indutseerija; cyp3a4 inhibiitor ja substraat)

combination with potent cyp3a4 inhibitors (eg. ketoconazole, itraconazole, ritonavir) (see section 4.5).
kombineerimine tugevate cyp3a4 inhibiitoritega (nt ketokonasool, itrakonasool, ritonaviir) (vt lõik 4. 5).

this especially holds true when taking potent cyp3a4 inhibitors (see sections 4.2, 4.5 and 5.1).
see kehtib eelkõige tugevatoimeliste cyp3a4 inhibiitorite kasutamisel (vt lõigud 4.2, 4.5 ja 5.1).

apremilast can be co-administered with a potent cyp3a4 inhibitor such as ketoconazole.
apremilasti võib manustada koos cyp3a4 tugevatoimelise inhibiitori ketokonasooliga.

- co-administration of the potent cyp3a4 inhibitor ketoconazole increased the peak plasma
suukaudne